Boston Scientific Corporation
BSX
$73.85
-$2.37-3.11%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 672.00M | 755.00M | 797.00M | 674.00M | 565.00M |
| Total Depreciation and Amortization | 365.00M | 342.00M | 336.00M | 325.00M | 348.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 172.00M | 202.00M | -80.00M | 220.00M | 219.00M |
| Change in Net Operating Assets | 155.00M | 44.00M | 233.00M | -678.00M | 324.00M |
| Cash from Operations | 1.36B | 1.34B | 1.29B | 541.00M | 1.46B |
| Capital Expenditure | -351.00M | -181.00M | -157.00M | -187.00M | -277.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -89.00M | -256.00M | -1.01B | -239.00M | -3.42B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -72.00M | -65.00M | 40.00M | -74.00M | -9.00M |
| Cash from Investing | -512.00M | -502.00M | -1.13B | -500.00M | -3.70B |
| Total Debt Issued | 0.00 | 0.00 | 0.00 | 1.56B | 187.00M |
| Total Debt Repaid | -209.00M | -215.00M | -314.00M | -1.31B | 0.00 |
| Issuance of Common Stock | 20.00M | 115.00M | 32.00M | 115.00M | 28.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5.00M | -4.00M | -58.00M | -129.00M | -1.00M |
| Cash from Financing | -184.00M | -104.00M | -340.00M | 233.00M | 214.00M |
| Foreign Exchange rate Adjustments | 3.00M | -2.00M | 2.00M | 39.00M | -9.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00M |
| Net Change in Cash | 671.00M | 735.00M | -178.00M | 313.00M | -2.04B |